Aethlon Medical appoints Nicolas Gikakis to Board of Directors

AETHLON MEDICAL INC

Nicolas Gikakis appointed to Board and Nominating Committee effective July 3, 2023.
Received RSU grant for 195,414 shares vesting quarterly over one year.
Annual cash retainers: $40,000 for Board service plus $5,000 for Nominating Committee.
Gikakis brings experience in blood filtration/purification and medical device commercial strategy.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Nicolas Gikakis

Director

AEMD · AETHLON MEDICAL INC

Effective: 2023-07-03
Filed: July 6, 2023, 7:59 PM ET

appointed Nicolas Gikakis as (i) a member of the Board, and (ii) a member of the Nominating Committee.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Nicolas Gikakis was appointed as Director at AETHLON MEDICAL INC.

Action: appointed
Role: Director

Exact text from the filing

appointed Nicolas Gikakis as (i) a member of the Board, and (ii) a member of the Nominating Committee.

View on SEC.gov

AETHLON MEDICAL INC filing history →

Source: SEC EDGAR

accession 0001683168-23-004695

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.